Back to Peptides

KPV

Emerging

Anti-Inflammatory Tripeptide | Alpha-MSH Fragment

Dose 200-500 mcg per injection
Frequency 1-2 times daily (once for maintenance, twice for active inflammation)
Cycle 4-8 weeks
Storage Lyophilized: Room temperature. Reconstituted: 2-8°C, refrigerate immediately

KPV is a potent anti-inflammatory tripeptide derived from the C-terminal of alpha-MSH. It exhibits remarkable anti-inflammatory and antimicrobial properties without the pigmentation effects of full α-MSH, making it ideal for inflammation management.

Mechanism of Action

Enters cells and inhibits inflammatory pathways at the nuclear level, particularly NF-κB signaling. Reduces pro-inflammatory cytokines (TNF-α, IL-6) without causing immunosuppression like steroids.

Key Benefits

  • Systemic anti-inflammatory effects
  • No pigmentation/tanning effects
  • Immune modulation without immunosuppression
  • Potential for autoimmune conditions
  • Gut health support
  • Multiple delivery routes available
Chain Length
3 amino acids
Type
Tripeptide

Inflammation

  • Systemic Inflammation

    Reduces TNF-α and IL-6 through NF-κB pathway inhibition.

  • Autoimmune Modulation

    May help balance overactive immune responses in autoimmune conditions.

  • Joint Inflammation

    Potential benefits for inflammatory arthritis through cytokine reduction.

Gut Health

  • IBD Support

    Demonstrated benefit in Crohn's disease and ulcerative colitis models.

  • Intestinal Barrier Repair

    Helps restore intestinal barrier function.

  • Microbiome Balance

    Selective antimicrobial activity preserves beneficial gut bacteria.

Skin Health

  • Psoriasis/Dermatitis

    Topical KPV reduced psoriatic markers by 60% and improved skin barrier function.

  • Skin Inflammation

    Reduces inflammatory skin conditions without systemic effects.

Subcutaneous injection provides systemic anti-inflammatory effects. Abdomen is preferred for gut-related issues.

GoalDoseFrequencyRoute
General anti-inflammatory200-300mcgOnce dailySubQ
Active inflammation250mcgTwice dailySubQ
Autoimmune support500mcgOnce dailySubQ
Acute flare-ups500mcg2x daily for 1 week, then reduceSubQ

Reconstitution Instructions

Materials Needed:
  • KPV lyophilized powder
  • Bacteriostatic water
  • Insulin syringes
  • Alcohol swabs
  1. 1 Clean vial with alcohol pad
  2. 2 Add 1mL bacteriostatic water to 1mg vial (1000mcg/mL)
  3. 3 Or add 2mL for 500mcg/mL concentration
  4. 4 Gently swirl - dissolves easily
  5. 5 Solution should be clear and colorless
  6. 6 Label with concentration and date
  7. 7 Refrigerate immediately
BPC-157

Enhanced gut healing and anti-inflammatory effects through complementary mechanisms.

synergistic
TB-500

Different mechanisms; can be combined safely.

compatible
LL-37

Complementary antimicrobial and healing effects.

synergistic
Thymosin Alpha-1

Both support immune function through different pathways.

compatible
GHK-Cu

Synergistic for skin health and regeneration.

synergistic
Melanotan II

Both are α-MSH related; KPV lacks pigmentation effects but monitor for cumulative effects.

monitor
Days 1-3

Subtle reduction in inflammation, improved energy

Week 1

Noticeable decrease in inflammatory symptoms

Week 2-3

Improved gut function (if applicable), reduced pain/swelling

Week 4

Significant improvement in inflammatory markers

Week 6-8

Sustained benefits, improved quality of life

Common Side Effects

  • Minimal to no side effects reported
  • Does not cause immunosuppression like steroids
  • No melanin production/tanning effects
  • May temporarily reduce inflammation-related symptoms

Stop Signs - Discontinue if:

  • Signs of infection (fever, chills) - very rare
  • Severe injection site reactions
  • Paradoxical inflammation increase
  • Allergic reaction symptoms
  • Unusual fatigue or weakness

Contraindications

  • Known peptide allergies
  • Active severe infections (theoretical)
  • Pregnancy or breastfeeding (limited data)

Good Signs

  • High purity >98%
  • Clear, colorless solution after reconstitution
  • Stable small peptide structure
  • Certificate of analysis available

Warning Signs

  • pH should be 5.5-7 for optimal stability

Bad Signs

  • Visible particles indicate contamination/degradation
  • Yellow coloration indicates oxidation/potency loss
  • KPV in IBD Models
    (2019)

    Demonstrated significant reduction in inflammatory markers and improved intestinal barrier function in IBD models.

  • Anti-Inflammatory Mechanisms Study
    (2020)

    KPV enters cells and directly inhibits NF-κB pathway, reducing TNF-α, IL-6, and other inflammatory cytokines.

  • Psoriasis/Dermatitis Study
    (2021)

    Topical KPV reduced psoriatic markers by 60% and improved skin barrier function.

  • Antimicrobial Properties Study
    (2022)

    Showed selective antimicrobial activity against pathogenic bacteria while preserving beneficial gut microbiota.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.